Search clinical trials for: Lilly glucagon

Total 560 results

Eli Lilly and Company
Locemia Solutions ULC

Completed

A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults

Healthy

Canada
University of Maryland, Baltimore

Active, not recruiting

GLP-1 and Hypoglycemia

Type 2 Diabetes Mellitus

United States
Oslo University Hospital

Completed

GLP-1 Effects on Insulin and Glucagon in PTDM

Post-transplant Diabetes Mellitus

Norway
University of Aarhus

Completed

Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET

Healthy

Denmark
University Health Network, Toronto

Completed

Assessment of Intranasal Glucagon on Endogenous Glucose Production

Diabetes
Acibadem University

Completed

Comparing Basic Life Support Performance With Serious Game Based Module and Simulation Based Hands on Training

Cardiopulmonary Resuscitation | Simulation Training

Turkey
Imperial College London

Completed

Investigating Brown Adipose Tissue Activation in Humans

Metabolic Diseases

United Kingdom
Eli Lilly and Company
Locemia Solutions ULC

Completed

A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Canada
DiObex

Completed

A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus

Type 1 Diabetes

United States
Uppsala University
Karolinska Institutet; University of Copenhagen

Completed

GIP and GLP-1 on Gastric Emptying, Appetite and Insulin-glucose (GIP-GLP-gas)

Physiology | Gastroenterology | Endocrinology

Sweden
University of Aarhus
Danish Council for Independent Research

Completed

Glucagon Resistance in Patients With NAFLD

Glucose Metabolism Disorders | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis

Denmark
University Hospital Tuebingen

Completed

Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose Challenge

Diabetes | Metabolic Syndrome

Germany
Hvidovre University Hospital

Completed

Beta-Cell Function After Near-Normalisation of Blood Glucose

Type 2 Diabetes

Denmark
Ali Aminian

Not yet recruiting

Fibrosis Lessens After Metabolic Surgery (FLAMES)

Obesity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Metabolic Dysfunction-Associated Steatohepatitis (MASH)

United States, Sweden, Ireland, Finland, United Kingdom, Spain, Switzerland, Brazil, Canada, Italy, Kuwait, India, Mexico
University of Florida
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Effects of Exenatide on Motor Function and the Brain

Parkinson's Disease

United States
Imperial College London

Not yet recruiting

Liver Fat and Glucagon Resistance

Steatosis of Liver
Eli Lilly and Company
Locemia Solutions ULC

Terminated

A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Canada
Papworth Hospital NHS Foundation Trust

Completed

The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure

Heart Failure

United Kingdom
Eli Lilly and Company

Completed

A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes (RescuiNGkids)

Type 1 Diabetes

United States
University Hospital, Gentofte, Copenhagen
The Novo Nordisk Foundation Center for Basic Metabolic Research

Completed

The Role of the Kidneys and Liver in the Elimination of Glucagon (MCR_EndCir)

Liver Cirrhosis | Chronic Kidney Diseases | Hyperglucagonemia

Denmark
University of Copenhagen
Hvidovre University Hospital

Completed

Effects of Gut Peptides on Bone Remodeling (KS-3)

Healthy

Denmark
Abby Braitman
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Alcohol Health Education Among College Drinkers

College Student Drinking
Indiana University

Completed

Scheduled Awakenings for the Treatment of Nocturnal Enuresis

Nocturnal Enuresis

United States
Boston University Charles River Campus
Massachusetts General Hospital; National Institute of Diabetes and Digestive... and other collaborators

Completed

Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas (CL2)

Diabetes Mellitus

United States
Baylor College of Medicine

Completed

The Role of Amylin and Glucagon in T1DM

Type 1 Diabetes

United States
National Institute of Diabetes and Digestive and...
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials

Diabetes Mellitus, Type 1

United States, Australia, Canada, Finland, Italy, United Kingdom
Wake Forest University Health Sciences

Active, not recruiting

SNIFF Multi-Device Study 2

Cognitive Impairment | Mild Cognitive Impairment

United States
University of Copenhagen
Hvidovre University Hospital

Completed

Gut Hormones and Bone Remodeling in Humans (KS-2) (KS-2)

Healthy

Denmark
Mikkel Christensen

Completed

Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes

Type 1 Diabetes Mellitus
Medical University of Vienna
Medical University of Graz; Charite University, Berlin, Germany; Hospital del...

Completed

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients (ITP-NODAT)

Hyperglycemia
Novo Nordisk A/S

Not yet recruiting

Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different Treatments

Diabetes Mellitus, Type 2
Zealand Pharma
Massachusetts General Hospital; Beta Bionics, Inc.

Completed

Feasibility Trial Testing the Bionic Pancreas With ZP4207 (dasiglucagon)

Diabetes Mellitus, Type 1

United States
Kaplan Medical Center

Unknown

Best Timing of Insulin Bolus Before Meals of Different Contents

Type 1 Diabetes Mellitus

Israel
Sciwind Biosciences APAC CO Pty. Ltd.
Hangzhou Sciwind Biosciences Co., Ltd.

Completed

Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

Obesity

Australia
AstraZeneca

Completed

Clinical Outcomes of Exenatide Versus Basal Insulin

Type 2 Diabetes

United Kingdom
Steno Diabetes Center Copenhagen

Unknown

Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects

Effect of Glucagon-like Peptide 2 on Gallbladder Motility

Denmark
Hennepin Healthcare Research Institute
Eli Lilly and Company

Completed

Inpatient Diabetes on Corticosteroids

Diabetes Mellitus

United States
Massachusetts General Hospital
Boston University

Completed

Closed-Loop Glucagon Administration For Hypoglycemia Treatment

Type 1 Diabetes

United States
Nanjing Medical University
Beijing Anzhen Hospital

Not yet recruiting

Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Sivelestat) VI

Systemic Inflammatory Response Syndrome | Aortic Dissection

China
Massachusetts General Hospital
Sanofi

Completed

Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon (DAWN)

Type 1 Diabetes | Dawn Phenomenon

United States
GlyPharma Therapeutics
VectivBio AG

Completed

Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support

Short Bowel Syndrome

Denmark
Centre Hospitalier Universitaire de Nice

Recruiting

Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery (Maigrir_OT)

Obesity

France
University of Copenhagen
Hvidovre University Hospital

Recruiting

Gut Peptides and Bone Remodeling in Individuals With Spinal Cord Injury

Spinal Cord Injuries

Denmark
University of Copenhagen
Copenhagen University Hospital, Hvidovre

Recruiting

Co-infusion of Neurotensin and GLP-1 Effects on Appetite and Food Intake.

Obesity

Denmark
University Hospital, Gentofte, Copenhagen
Merck Sharp & Dohme LLC

Completed

Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Denmark
Bayer

Active, not recruiting

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice (FINEGUST)

Type 2 Diabetes Mellitus | Chronic Kidney Disease

Japan, Spain, Netherlands, United Kingdom, Denmark, United States
Oslo Metropolitan University
University of Oslo; Nofima; Mills DA

Completed

Intake of Beta-glucan and Postprandial Regulation of Blood Glucose Metabolism in Healthy Subjects

Gut Microbiota | Satiety | Post Prandial Blood Glucose

Norway
Hvidovre University Hospital

Completed

Incretin Hormone Antagonism After Bariatric Surgery (INCA-BAR)

Bariatric Surgery

Denmark
Second Xiangya Hospital of Central South University
Guangdong Provincial People's Hospital; The First Affiliated Hospital of Henan... and other collaborators

Recruiting

The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.

Diabetes Mellitus, Type 2 | Overweight or Obesity

China
Boehringer Ingelheim

Completed

Evaluating Comparative Effectiveness of Empagliflozin in Type 2 Diabetes Population With and Without Chronic Kidney Disease

Diabetes Mellitus, Type 2

United States

Search clinical trials for: Lilly glucagon

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations